Abstract |
Nine patients with complicated hydatid disease managed with surgery and mebendazole/ albendazole are presented. Five patients received albendazole (1 treatment course) and 5 patients received mebendazole (3 had 2 treatment courses, 1 had a switch-over from mebendazole to albendazole). The mean durations of treatment and follow-up were respectively 7 +/- 2.5 months and 7 +/- 2.5 months ( albendazole); 13 +/- 10 months and 29 +/- 31 months ( mebendazole). A superior clinical and radiological response was seen in 1 patient with disseminated intra-abdominal disease on switching therapy from mebendazole to albendazole. Radiological improvement occurred in 3/5 courses of albendazole and in 2/8 courses of mebendazole. Clinical improvement occurred in 3/5 courses of albendazole and 0/8 courses of mebendazole. Radiological deterioration was demonstrated in 0/5 courses of albendazole and 2/8 courses of mebendazole. Although the impression was that albendazole was superior, good responses were also seen with mebendazole. The heterogeneity of the patients, their disease, short follow-up time, lack of more sensitive noninvasive assay techniques urges caution before firm conclusions can be drawn.
|
Authors | M Ellis, W von Sinner, A Al-Hokail, J Sieck |
Journal | Scandinavian journal of infectious diseases
(Scand J Infect Dis)
Vol. 24
Issue 1
Pg. 1-13
( 1992)
ISSN: 0036-5548 [Print] England |
PMID | 1589713
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
|
Topics |
- Abdomen
(surgery)
- Adult
- Aged
- Albendazole
(therapeutic use)
- Child
- Debridement
- Drug Therapy, Combination
- Echinococcosis
(diagnostic imaging, drug therapy, surgery, therapy)
- Echinococcosis, Hepatic
(diagnostic imaging, drug therapy, surgery)
- Female
- Humans
- Male
- Mebendazole
(therapeutic use)
- Middle Aged
- Time Factors
- Tomography, X-Ray Computed
|